Hepatitis Monthly

Published by: Kowsar

The Long-Term Outcomes for Patients with Budd-Chiari Syndrome Caused by Behcet’s Disease: A Case Series on the Results, from Cirrhosis to Death

Dondu Uskudar Cansu 1 , * , Tuncer Temel 2 , Adem Erturk 1 , Timucin Kasifoglu 1 , Berat Acu 3 and Cengiz Korkmaz 1
Authors Information
1 Division of Rheumatology, Department of Internal Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
2 Division of Gastroenterology, Department of Internal Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
3 Department of Radiology, Eskisehir Osmangazi University, Eskisehir, Turkey
Article information
  • Hepatitis Monthly: 16 (10); e58746
  • Published Online: September 19, 2016
  • Article Type: Research Article
  • Received: August 15, 2015
  • Revised: August 16, 2016
  • Accepted: August 17, 2016
  • DOI: 10.5812/hepatmon.32457

To Cite: Cansu D U, Temel T, Erturk A, Kasifoglu T, Acu B, et al. The Long-Term Outcomes for Patients with Budd-Chiari Syndrome Caused by Behcet’s Disease: A Case Series on the Results, from Cirrhosis to Death, Hepat Mon. Online ahead of Print ; 16(10):e58746. doi: 10.5812/hepatmon.32457.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003; 82(1): 60-76[PubMed]
  • 2. Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Behcet disease: evolution of clinical manifestations. Medicine (Baltimore). 2011; 90(2): 125-32[DOI][PubMed]
  • 3. Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology. 2003; 38(4): 793-803[DOI][PubMed]
  • 4. Uskudar O, Akdogan M, Sasmaz N, Yilmaz S, Tola M, Sahin B. Etiology and portal vein thrombosis in Budd-Chiari syndrome. World J Gastroenterol. 2008; 14(18): 2858-62[PubMed]
  • 5. Harmanci O, Kav T, Peynircioglu B, Buyukasik Y, Sokmensuer C, Bayraktar Y. Long-term follow-up study in Budd-Chiari syndrome: single-center experience in 22 years. J Clin Gastroenterol. 2013; 47(8): 706-12[DOI][PubMed]
  • 6. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990; 335(8697): 1078-80[PubMed]
  • 7. Bhakta B, Hamuryudan V, Brennan P, Chamberlain MA, Barnes C, Silman AJ. Assessment of disease activity in Behcet's disease. Excerpta medica international congress series 1037, 611. 1993; : 235-40
  • 8. Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H. Vascular involvement in Behcet's syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford). 2014; 53(11): 2018-22[DOI][PubMed]
  • 9. Horton JD, San Miguel FL, Membreno F, Wright F, Paima J, Foster P, et al. Budd-Chiari syndrome: illustrated review of current management. Liver Int. 2008; 28(4): 455-66[DOI][PubMed]
  • 10. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd-Chiari syndrome: a common complication of Behcet's disease. Am J Gastroenterol. 1997; 92(5): 858-62[PubMed]
  • 11. Mahmoud AE, Helmy AS, Billingham L, Elias E. Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis. Eur J Gastroenterol Hepatol. 1997; 9(5): 485-9[PubMed]
  • 12. Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol. 2006; 101(1): 83-90[DOI][PubMed]
  • 13. Bagheri Lankarani K, Homayon K, Motevalli D, Heidari ST, Alavian SM, Malek-Hosseini SA. Risk Factors for Portal Vein Thrombosis in Patients With Cirrhosis Awaiting Liver Transplantation in Shiraz, Iran. Hepat Mon. 2015; 15(12)[DOI][PubMed]
  • 14. Ren W, Qi X, Yang Z, Han G, Fan D. Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review. Eur J Gastroenterol Hepatol. 2013; 25(7): 830-41[DOI][PubMed]
  • 15. Bayraktar Y, Egesel T, Saglam F, Balkanci F, Van Thiel DH. Does hepatic vein outflow obstruction contribute to the pathogenesis of hepatocellular carcinoma? J Clin Gastroenterol. 1998; 27(1): 67-71[PubMed]
  • 16. Tanaka M, Wanless IR. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology. 1998; 27(2): 488-96[DOI][PubMed]
  • 17. Ames JT, Federle MP, Chopra K. Distinguishing clinical and imaging features of nodular regenerative hyperplasia and large regenerative nodules of the liver. Clin Radiol. 2009; 64(12): 1190-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments